Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 2545-2549, June 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thaler, F. J.
Right arrow Articles by Michalopoulos, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thaler, F. J.
Right arrow Articles by Michalopoulos, G. K.

Hepatopoietin A: Partial Characterization and Trypsin Activation of a Hepatocyte Growth Factor1

Fred J. Thaler2 and George K. Michalopoulos3

Division of Gastroenterology and Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710

Rat hepatocytes in primary culture are stimulated to synthesize DNA by high-molecular-weight fractions from rat serum. This activity has been previously given the name hepatopoietin A (HPTA). HPTA, with an apparent molecular weight of 150,000 to 250,000, stimulated the incorporation of [3H]thymidine into DNA, quantitated by autoradiography as percentage of nuclear labeling. Properties of HPTA include: sensitivity to heat; stability in minimal essential media at 4°C; in lyophilized form; or in 25% glycerol at -20°C; and instability at 4°C in isotonic buffer. Trypsin digestion of HPTA resulted in an increase in biological activity. Both the trypsinized and native forms of this activity were not inhibited by antiserum against mouse epidermal growth factor in this bioassay. Treatment of HPTA with trypsin resulted in a shift of its apparent molecular weight on a Sephadex G-50 column to <6000. This trypsinized HPTA activity did not comigrate with 125I-labeled epidermal growth factor on the same column. These results demonstrate that HPTA exists in normal serum as a large precursor to a more active moiety, generated by proteolytic cleavage, which is not identical to epidermal growth factor. Fractions from human serum and plasma of molecular weight similar to that of HPTA have also been shown to stimulate DNA synthesis in rat hepatocytes.

1 Supported by NIH Grant CA 35373.

2 Recipient of National Research Service Award AM 071669.

3 To whom requests for reprints should be addressed, at Department of Pathology, Box 3432, Duke University Medical Center, Durham, NC 27710.

Received 10/ 9/84. Revised 1/24/85. Accepted 3/ 8/85.




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. M. Hopkins, M. Bruewer, G. T. Brown, A. A. Pineda, J. J. Ha, L. M. Winfree, S. V. Walsh, B. A. Babbin, and A. Nusrat
Epithelial cell spreading induced by hepatocyte growth factor influences paxillin protein synthesis and posttranslational modification
Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G886 - G898.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
I. Iida, K. Johkura, R. Teng, S. Kubota, L. Cui, X. Zhao, N. Ogiwara, Y. Okouchi, K. Asanuma, J. Nakayama, et al.
Immunohistochemical Localization of Hepatocyte Growth Factor Activator (HGFA) in Developing Mouse Liver Tissues: Heterogeneous Distribution of HGFA Protein
J. Histochem. Cytochem., September 1, 2003; 51(9): 1139 - 1149.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Tamatani, K. Hattori, A. Iyer, K. Tamatani, and R. Oyasu
Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro
Carcinogenesis, June 1, 1999; 20(6): 957 - 962.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Schaper and T. Kubin
Is Hepatocyte Growth Factor a Protein With Cardioprotective Activity in the Ischemic Heart?
Circulation, June 3, 1997; 95(11): 2471 - 2472.
[Full Text]


Home page
J. Cell Sci.Home page
P Clark
Modulation of scatter factor/hepatocyte growth factor activity by cell-substratum adhesion
J. Cell Sci., January 5, 1994; 107(5): 1265 - 1275.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.